LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $13,282,000 | +9.4% | 85,990 | -1.3% | 1.46% | +4.1% |
Q3 2021 | $12,136,000 | +406.9% | 87,110 | +377.4% | 1.40% | +424.3% |
Q2 2021 | $2,394,000 | +12.3% | 18,245 | +30.5% | 0.27% | +8.5% |
Q1 2021 | $2,132,000 | -74.9% | 13,985 | -77.7% | 0.25% | -78.4% |
Q4 2018 | $8,504,000 | -33.0% | 62,671 | +35.6% | 1.14% | -0.7% |
Q3 2018 | $12,686,000 | -20.7% | 46,217 | -40.2% | 1.15% | -21.8% |
Q2 2018 | $16,004,000 | +14.5% | 77,247 | -8.7% | 1.47% | +7.3% |
Q1 2018 | $13,982,000 | -4.5% | 84,652 | -20.8% | 1.37% | +32.7% |
Q4 2017 | $14,634,000 | -24.1% | 106,887 | -24.5% | 1.03% | -18.6% |
Q3 2017 | $19,283,000 | -8.3% | 141,626 | -18.3% | 1.27% | -9.9% |
Q2 2017 | $21,039,000 | +14.0% | 173,291 | -0.7% | 1.41% | +15.0% |
Q1 2017 | $18,463,000 | +2.2% | 174,456 | -1.9% | 1.23% | +10.3% |
Q4 2016 | $18,064,000 | -14.7% | 177,771 | -14.3% | 1.11% | -10.6% |
Q3 2016 | $21,182,000 | +1.3% | 207,496 | +18.3% | 1.24% | +2.1% |
Q2 2016 | $20,912,000 | – | 175,331 | – | 1.22% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |